Healthcare technology company Cue Health has launched a new feature on its mobile application, Cue Care.
Cue Care allows patients to consult virtually, obtain a prescription and have the medication delivered. Cue Health plans to expand this service to patients who test positive for COVID-19 and provide an antiviral at-home kit for between $79 and $99, according to an Aug. 29 Cue Health news release.
"Early diagnosis and treatment have shown to lead to better health outcomes, which is why we're proud to deliver timely testing and treatment all within the Cue Health App," Cue Health CEO Ayub Khattak said. "Cue Care meets the need today for convenient delivery of COVID-19 treatment, and this capability will support our expanding pipeline of future diagnostics tests."